Heilongjiang Zbd Pharmaceutical Co.,Ltd.’s Net Profit Dropped 42.6% in 2022

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (黑龙江珍宝岛药业股份有限公司) (603567.SH) reported a net profit of 190.9 million yuan in 2022, down 42.6% year-on-year.

Meanwhile, the company posted 4.2 billion yuan in revenue, up 2.2% year-on-year.

At the end of the reporting period, it had 11.7 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 39.1%.